These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38779519)

  • 1. Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions.
    Li L; Li ZZ; Pan LX; Su JY; Huang S; Ma L; Zhong JH
    J Clin Transl Hepatol; 2024 May; 12(5):525-533. PubMed ID: 38779519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma.
    Zhang W; Zhang B; Chen XP
    Front Med; 2021 Apr; 15(2):155-169. PubMed ID: 33754281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress and perspectives on adjuvant therapy after curative resection of hepatocellular carcinoma].
    Liang TB
    Zhonghua Wai Ke Za Zhi; 2021 Oct; 59(10):801-806. PubMed ID: 34619903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
    Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
    Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects.
    Guo B; Chen Q; Liu Z; Chen X; Zhu P
    Front Oncol; 2023; 13():1098958. PubMed ID: 37139151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy.
    Lu SD; Li L; Liang XM; Chen W; Chen FL; Fan LL; Ahir BK; Zhang WG; Zhong JH
    Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1077-1088. PubMed ID: 31648568
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma.
    Chong CC; Cheung ST; Cheung YS; Chan AW; Chan SL; Yu SC; Lai PB
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):524-530. PubMed ID: 30413348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new era.
    Zhong JH
    World J Gastroenterol; 2024 Feb; 30(8):806-810. PubMed ID: 38516235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China.
    Wu Z; Cui L; Qian J; Luo L; Tu S; Cheng F; Yuan L; Zhang W; Lin W; Tang H; Li X; Li H; Zhang Y; Zhu J; Li Y; Xiong Y; Hu Z; Peng P; He Y; Liu L; He K; Shen W
    BMC Cancer; 2023 Apr; 23(1):325. PubMed ID: 37029339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative therapy options for hepatocellular carcinoma.
    Zhong JH; Ma L; Li LQ
    Scand J Gastroenterol; 2014 Jun; 49(6):649-61. PubMed ID: 24716523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects.
    Zhu XD; Li KS; Sun HC
    Genes Dis; 2020 Sep; 7(3):359-369. PubMed ID: 32884990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Shen A; Liu M; Zheng D; Chen Q; Wu Z
    Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
    Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
    Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated postoperative adjuvant TACE after curative hepatectomy improves outcomes of patients with HCC.
    Feng AL; Zhu JK; Yang Y; Wang YD; Liu FY; Zhu M; Liu CZ
    Minim Invasive Ther Allied Technol; 2021 Jun; 30(3):163-168. PubMed ID: 31880482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant ICIs Plus Targeted Therapies Reduce HCC Recurrence after Hepatectomy in Patients with High Risk of Recurrence.
    Yang J; Jiang S; Chen Y; Zhang J; Deng Y
    Curr Oncol; 2023 Jan; 30(2):1708-1719. PubMed ID: 36826093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-based skeletal muscle loss for predicting poor survival in patients with hepatocellular carcinoma experiencing curative hepatectomy plus adjuvant transarterial chemoembolization: a preliminary retrospective study.
    Yang S; Zhang Z; Su T; Yu J; Cao S; Wang H; Jin L
    Eur J Med Res; 2022 Jul; 27(1):131. PubMed ID: 35879734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma.
    Lee SK; Lee SW; Jang JW; Bae SH; Choi JY; Yoon SK
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.
    Huang K; Qian T; Chen W; Lao M; Li H; Lin WC; Chen BW; Bai X; Gao S; Ma T; Liang T
    BMC Cancer; 2024 May; 24(1):620. PubMed ID: 38773564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: a systematic review.
    Lau WY; Lai EC; Lau SH
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):124-33. PubMed ID: 19357024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.